Skip to main content

Table 4 Percentage of TG to target level and outcomes comparison in matched cohort with fenofibrate set as covariate

From: Therapeutic plasma exchange decreases serum triglyceride level rapidly and reduces early recurrence rate but no advantages in improving outcomes for patients with hyperlipidemic acute pancreatitis: a retrospective propensity score matching analysis based on twenty year’s experience

 

Matched cohort

 

n-TPE (n = 33)

TPE (n = 39)

p

Percentage of TG to target level in 2 daysa

0.09% (1/11)

68.75% (11/16)

0.046

without fenofibrate

with fenofibrate

TPE without fenofibrate

TPE with fenofibrate

 

0.09 (1/11)

0 (0/5)

68.75% (11/16)

16.66% (2/12)

 

P = 0.500b

P = 0.126b

 

Percentage of TG to targer level in 3 daysa

44.44% (4/9)

68.75% (11/16)

0.912

without fenofibrate

with fenofibrate

TPE without fenofibrate

TPE with fenofibrate

 

44.44% (4/9)

17.64% (3/17)

50.00% (8/16)

13.33% (2/15)

 

P = 0.151b

P = 0.032b

 

CTSI changes in 14 days

 Improved

61.54% (8/13)

42.11% (8/19)

0.288

 Deteriorated

38.46% (5/13)

36.84% (7/19)

0.927

 Unchanged

0

21.05% (4/19)

 

Early recurrence (in 3 months)

1

0

 

Local complicationsc

31.25% (5/16)

31.58% (6/19)

0.984

Mortality

0

0

 
  1. aTG level < 5.65 mmol/L was set as the target level
  2. bcompare the group with or without fenofibrate
  3. cOnly those have their CT rechecked within 6 months included